Neoplasm Test

Question 0

What is a malignant secondary neoplasm?

Answer 0

A tumor that has spread to other parts of the body.

Question 1

What is a malignant primary neoplasm?

Answer 1

The origin of the malignant tumor.

Question 2

What is Ca in situ?

Answer 2

A neoplasm undergoing malignant changes but still confined to point of origin w/o invasion of surrounding tissue.

Question 3

What is a benign neoplasm?

Answer 3

Not malignant, noninvasive tumor that does not spread to a distant site, encapsulated.

Question 4

What is a neoplasm of uncertain behavior?

Answer 4

Behavior cannot be predicted. We don’t know what it’s going to turn into or do.

Question 5

What is a neoplasm of unspecified behavior?

Answer 5

Unspecified as to either behavior type or morphology. We don’t know anything about the tumor.

Question 6

Always presume a site is _________unless specified.

Answer 6

Primary

Question 7

True or False: a patient may have more than one primary site?

Answer 7

True

Question 8

If there is no morphology type, which parts of the body should be coded as a secondary site?

Answer 8

Bone, brain, diaphragm, heart, lymph nodes, mediastinum, meninges, peritoneum, pleura, retroperitoneum, spinal cord.

Question 9

When dealing with metastatic neoplasms, there should be at least how many codes?

Answer 9

Two

Question 10

What is the code for undetermined primary neoplasm?

Answer 10

C80.1

Question 11

What is the code for an undetermined secondary neoplasm?

Answer 11

C79.9

Question 12

What does metastatic “from” indicate?

Answer 12

The site mentioned is primary.

Question 14

What does metastatic “to” indicate?

Answer 14

The site mentioned is secondary.

Question 15

What do you code an unspecified mass or legion to?

Answer 15

Code to mass, lesion lump, disease.

Question 16

What is morphology?

Answer 16

The form and structure of tumor cells.

Question 17

What are the two types of malignant neoplasms?

Answer 17

Solid and Hematopoietic Lymphatic.

Question 18

What are solid neoplasms?

Answer 18

Single, localized point of origin and are considered to be primary neoplasms of that site. Tend to spread to adjacent or remote sites.

Question 19

What are hematopoietic lymphatic neoplasms?

Answer 19

Single site or several sites simultaneously. Tumor cells often circulate in large numbers in blood stream and lymphatic system or spread to other sites in the hematopoietic and lymphatic system. Never a secondary site.

Question 20

What are overlapping/contiguous sites?

Answer 20

Next to each other. Use the code number .8

Question 21

What is the code for no known primary or secondary site?

Answer 21

C80.0

Question 22

How do you sequence neoplasms?

Answer 22

By principal diagnosis.

Question 23

How do you sequence treatments at primary sites?

Answer 23

The primary site first then the secondary site second.

Question 24

What are the exceptions to coding treatments of primary sites first?

Answer 24

Chemotherapy, immunotherapy and radiation. Use the code Z51.- then code the diagnosis or problem as a secondary diagnosis.

Question 25

How do you sequence treatments at secondary sites?

Answer 25

The secondary site is the principal diagnosis. Code for primary site is a secondary code.

Question 26

How do you code an admission for complication with a malignant neoplasm?

Answer 26

Code the complication as principal then the neoplasm as the second code.

Question 27

How do you code anemia?

Answer 27

Neoplasm as principal, then anemia.

Question 28

How do you code anemia with an adverse effect of therapy?

Answer 28

Anemia as principal, neoplasm second.

Question 29

How do you code a complication from surgery?

Answer 29

Admission is for the complication so code it as principal. The neoplasm would be the secondary code.

Question 30

How do you code an encounter to determine the extent of malignancy?

Answer 30

Code primary or secondary malignancy as principal, even though chemotherapy or radiotherapy is administered.

Question 31

How would you code a patient that is still undergoing treatment?

Answer 31

Code primary or secondary site as principal. Even if malignancy has been excised.